Compounds > celecoxib

celecoxib and meglumine

celecoxib has been researched along with meglumine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Bansal, AK; Gupta, P	3
Bansal, AK; Dantuluri, AK; Puri, V	2

Other Studies

6 other study(ies) available for celecoxib and meglumine

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Molecular interactions in celecoxib-PVP-meglumine amorphous system. The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Celecoxib; Drug Stability; Meglumine; Models, Molecular; Povidone; Pyrazoles; Solubility; Spectroscopy, Fourier Transform Infrared; Sulfonamides	2005
Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine. Pharmaceutical development and technology, 2005, Volume: 10, Issue:2 Topics: Air Pressure; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Celecoxib; Chromatography, High Pressure Liquid; Desiccation; Drug Compounding; Drug Stability; Excipients; Meglumine; Microscopy, Electron, Scanning; Particle Size; Povidone; Pyrazoles; Solubility; Solutions; Solvents; Spectroscopy, Fourier Transform Infrared; Sulfonamides; Temperature; X-Ray Diffraction	2005
Ternary amorphous composites of celecoxib, poly(vinyl pyrrolidone) and meglumine with enhanced solubility. Die Pharmazie, 2005, Volume: 60, Issue:11 Topics: Calorimetry, Differential Scanning; Celecoxib; Cyclooxygenase 2 Inhibitors; Half-Life; Meglumine; Microscopy, Polarization; Nonlinear Dynamics; Pharmaceutic Aids; Povidone; Pyrazoles; Solubility; Sulfonamides; Temperature; Thermodynamics; Water	2005
Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion. Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:6 Topics: Calorimetry, Differential Scanning; Capsules; Celecoxib; Compressive Strength; Crystallization; Cyclooxygenase 2 Inhibitors; Drug Compounding; Drug Stability; Meglumine; Microscopy, Electron, Scanning; Molecular Structure; Phase Transition; Povidone; Powders; Pyrazoles; Solubility; Spectroscopy, Fourier Transform Infrared; Sulfonamides; Surface Properties; X-Ray Diffraction	2011
Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form. Journal of pharmaceutical sciences, 2012, Volume: 101, Issue:1 Topics: Capsules; Celecoxib; Cellulose; Chemistry, Pharmaceutical; Coated Materials, Biocompatible; Crystallization; Drug Compounding; Drug Stability; Excipients; Inulin; Meglumine; Pharmaceutical Preparations; Polyvinyl Alcohol; Polyvinyls; Povidone; Pyrazoles; Solubility; Sulfonamides; Temperature	2012